Tizanidine Tablet
Product Images NDC 64980-658
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Tizanidine (NDC 64980-658). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Rising Pharma Holdings, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image (3edde2f7 87aa 4ae9 Af8a Ddb012ff4862 02)
Image (3edde2f7 87aa 4ae9 Af8a Ddb012ff4862 03)
Image (3edde2f7 87aa 4ae9 Af8a Ddb012ff4862 04)
Image (3edde2f7 87aa 4ae9 Af8a Ddb012ff4862 05)
This text provides important information about Tizanidine tablets, including the dosage per tablet, storage instructions, and manufacturer details. Tizanidine tablets are formulated with 2 mg of tizanidine base per tablet and should not be confused with Zanaflex capsules. The tablets should be stored at a temperature of 25°C with permitted excursions, and should be kept in containers with child-resistant closures. For detailed prescribing information, reference should be made to the package insert. The product is manufactured by Graviti Pharmaceuticals Pvt. Ltd in India and distributed by Rising Pharma Holdings, Inc. in East Brunswick, NJ.*
Image (3edde2f7 87aa 4ae9 Af8a Ddb012ff4862 06)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.